Post-Operative Ambulatory Challenge and Exercise (PACE) Trial

Cancer Clinical Trial

Official title:

Post-Operative Ambulatory Challenge and Exercise (PACE) Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03234933
• Other study ID #: 17-152
• Status: Completed
• Phase: N/A
• Start date: August 2, 2017
• Est. completion date: April 1, 2020

Study information

• Verified date: April 2020
• Source: Dana-Farber Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research study is evaluating the postoperative results in terms of quality of life and functional recovery of elderly patients after cancer surgery.

Description:

This is a pilot study, designed to collect data on steps walked (ambulation) per day of lobectomy patients after surgery. While the investigators know ambulation improves outcomes after surgery, there is no institutional policy, set of patient goals, or method for deciding which patients require further resources, such as physical therapy. Data collected will be used to set up a hospital-wide strategy for patients to achieve post-operative ambulation milestones more readily.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: April 1, 2020
• Est. primary completion date: April 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients Aged = 18 years

• Who underwent or who will undergo lung resection at Brigham and Women's Hospital (BWH)

• With diagnosis of malignant or benign disease

Exclusion Criteria:

• Patients with baseline immobility (i.e. wheelchair-bound, use of any walking assistance device, or gait alterations)

• Patients with cognitive deficits

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Mobility Tracker
Tracking Patient's movements and calories

Locations

Country	Name	City	State
United States	Brigham and Women's Hospital	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Dana-Farber Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Steps Taken	Number of steps taken by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.	2 years
Secondary	Distance walked	The distance walked by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.	2 years
Secondary	Number of Calories Burned	The number of calories burned by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.	2 years